In today's terrorism-prone world (see, for example, Nature 528, 7-8; 2015 and Nature 528, 20-21; 2015) , it is becoming increasingly important to ensure that buildings are designed to be speedily evacuated in an emergency.
Evacuation modelling is a relatively new field that uses computational tools to predict human behaviour in a stricken building. Algorithms represent the range of people's possible reactions in the event
Common doctorates across Europe
The German medical doctorate system is not the only element that needs changing to overcome the ills that you discuss (see Nature 527, 7; 2015). In our view, a European approach offers the best cure.
We suggest that Germany's medical degree should be modified to lead to a common European medical qualification: the vocational degree of Doctor of Medicine. Postgraduate medical research should be part of a different common European qualification: the academic degree of Doctor of Philosophy.
Scientific quality would be guaranteed if the criteria for attaining degrees were to be standardized across Europe, and if specialist postgraduate medical colleges were widely set up. Students and clinicians would then also be able to pursue their divergent scientific interests more easily.
A European core curriculum devised along these lines would reduce excessive pressure on students, enhance the mobility of students and graduates, and foster the growth of excellent health care and science. Such technological advances mean that cutting emissions can drive down the cost of further cuts in emissions (see go.nature. com/j8ueaj). For example, the price of photovoltaic modules for solar energy has fallen by 85% since 2000 as markets have grown; electricity costs from wind are now comparable to those from coal; and energystorage technologies are improving.
Publicly funded research and development, early investment by the private sector, and efficient deployment are all crucial for innovation. Market growth in renewable energy is largely driven by government policies, which have unleashed private companies' research ingenuity and achieved economies of scale and greater productivity (see also J. E. Trancik Nature 507, 300-302; 2014 
CORRECTION
The Outlook article 'Research without prejudice' (Nature 525, S12-S13; 2015) incorrectly stated that the approval of the US National Institute on Drug Abuse (NIDA) is required for US cannabis trials. In fact, NIDA provides cannabis for every project that has completed the government-mandated approval process. The article also implied that NIDA was holding up the start of a trial led by Sue Sisley, but the delay is caused by other circumstances.
